ロード中...
CD28z CARs and Armored CARs
CD19-targeted chimeric antigen receptor (CAR) T cells are currently being tested in the clinic with very promising outcomes. However, limitations to CAR T cell therapy exist. These include lack of efficacy against some tumors, specific targeting of tumor cells without affecting normal tissue and ret...
保存先:
| 出版年: | Cancer J |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4687893/ https://ncbi.nlm.nih.gov/pubmed/24667958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000034 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|